4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide

C32H33N5O3S — CID 46006242

IUPAC4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide
SMILESC=CCN(CC(=O)N1CCN(c2ccc(-c3ccc(-c4ccccc4)cc3)nn2)CC1)S(=O)(=O)c1ccc(C)cc1
InChIInChI=1S/C32H33N5O3S/c1-3-19-37(41(39,40)29-15-9-25(2)10-16-29)24-32(38)36-22-20-35(21-23-36)31-18-17-30(33-34-31)28-13-11-27(12-14-28)26-7-5-4-6-8-26/h3-18H,1,19-24H2,2H3
InChIKeyYVNSKWHMTGOTPF-UHFFFAOYSA-N
MW567.72 g/mol
LogP4.64
Rot. Bonds9

About 4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide

4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide (PubChem CID 46006242) has the molecular formula C32H33N5O3S and a molecular weight of 567.72 g/mol. Its IUPAC name is 4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide.

Molecular Properties

Compound Name4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide
PubChem CID46006242
Molecular FormulaC32H33N5O3S
Molecular Weight567.72 g/mol
Exact Mass567.23
IUPAC Name4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide
SMILESC=CCN(CC(=O)N1CCN(c2ccc(-c3ccc(-c4ccccc4)cc3)nn2)CC1)S(=O)(=O)c1ccc(C)cc1
InChIInChI=1S/C32H33N5O3S/c1-3-19-37(41(39,40)29-15-9-25(2)10-16-29)24-32(38)36-22-20-35(21-23-36)31-18-17-30(33-34-31)28-13-11-27(12-14-28)26-7-5-4-6-8-26/h3-18H,1,19-24H2,2H3
InChIKeyYVNSKWHMTGOTPF-UHFFFAOYSA-N
XLogP4.64
TPSA86.71 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds9
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500567.72
LogP ≤ 54.64
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide?
The IUPAC name of 4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide (CID 46006242) is 4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide.
What is the SMILES notation for 4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide?
The canonical SMILES for 4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide is C=CCN(CC(=O)N1CCN(c2ccc(-c3ccc(-c4ccccc4)cc3)nn2)CC1)S(=O)(=O)c1ccc(C)cc1.
What is the InChIKey of 4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide?
The InChIKey is YVNSKWHMTGOTPF-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H33N5O3S/c1-3-19-37(41(39,40)29-15-9-25(2)10-16-29)24-32(38)36-22-20-35(21-23-36)31-18-17-30(33-34-31)28-13-11-27(12-14-28)26-7-5-4-6-8-26/h3-18H,1,19-24H2,2H3.
What are the key properties of 4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide?
4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide has a molecular weight of 567.72 g/mol, XLogP of 4.64, 9 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-methyl-N-[2-oxo-2-[4-[6-(4-phenylphenyl)pyridazin-3-yl]piperazin-1-yl]ethyl]-N-prop-2-enylbenzenesulfonamide is sourced from PubChem (CID 46006242), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).